Business Description
![Bioasis Technologies Inc Bioasis Technologies Inc logo](https://static.gurufocus.com/logos/0C00000Q9G.png?14)
Bioasis Technologies Inc
NAICS : 325412
SIC : 3741
ISIN : CA09064N1033
Compare
Compare
Traded in other countries / regions
BTI.H.CanadaBIOAF.USA107.Germany IPO Date
2017-10-27Description
Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 81.36 | |||||
14-Day RSI | 68.9 | |||||
6-1 Month Momentum % | 1500 | |||||
12-1 Month Momentum % | 1500 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -696.02 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioasis Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.201 | ||
EPS (TTM) (€) | -0.024 | ||
Beta | 2.56 | ||
Volatility % | 1528.05 | ||
14-Day RSI | 68.9 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 0.008 | ||
12-1 Month Momentum % | 1500 | ||
52-Week Range (€) | 0.0005 - 0.015 | ||
Shares Outstanding (Mil) | 79.41 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bioasis Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bioasis Technologies Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Bioasis Technologies Inc Frequently Asked Questions
What is Bioasis Technologies Inc(FRA:107)'s stock price today?
The current price of FRA:107 is €0.01. The 52 week high of FRA:107 is €0.02 and 52 week low is €0.00.
When is next earnings date of Bioasis Technologies Inc(FRA:107)?
The next earnings date of Bioasis Technologies Inc(FRA:107) is .
Does Bioasis Technologies Inc(FRA:107) pay dividends? If so, how much?
Bioasis Technologies Inc(FRA:107) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |